Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Micro and Nanosystems
  4. Fast Track Articles
  5. Fast Track Article
image of Guiding Therapeutics: Lipid Labyrinths and Nanostructures for Enhanced Drug Delivery

Abstract

Nanostructured lipid carriers (NLCs) offer a breakthrough platform for drug therapy, surpassing traditional limitations and delivering exceptional performance. Among various nanoparticulate systems, lipid nanoparticles stand out as one of the most promising options for medication delivery. NLCs stand out due to their solid matrix at ambient temperatures, setting them apart from conventional lipid-based carriers such as nanoemulsions and solid lipid nanoparticles. This paper thoroughly explores the makeup, classification, components, and various methods of preparing NLCs, based on extensive research findings. It emphasizes their numerous advantages, such as improved stability, minimal toxicity, extended storage capability, increased drug-loading capacity, and compatibility with biological systems. The review provides insights into the advantages and limitations of each method. Exploring the intricacies of drug loading and release, the review also addresses strategies to bolster NLCs’ stability. Moreover, it provides a detailed summary of both laboratory-based and animal studies demonstrating the efficacy of NLCs carrying cytotoxic drugs, particularly emphasizing their promise in targeted drug delivery to the brain. As the next-generation lipid nanocarriers, NLCs are composed of physiological and biocompatible lipids, rendering them novel pharmaceutical formulations. These colloidal drug delivery systems boast a solid lipid matrix with nanosized structures, offering superior drug loading capacity, physical stability, and bioavailability compared to conventional lipid nanoparticles. Several techniques, including high-pressure homogenization, microemulsion, solvent evaporation, and melt emulsification, add to the flexibility of nanostructured lipid carriers. Additionally, their exterior can be altered using coatings such as polyethylene glycol, chitosan, or antibodies to improve targeting ability and stealth characteristics. By elucidating the promising role of NLCs across diverse drug delivery systems, this review stimulates interest in their potential applications. It underscores the significance of understanding the structure, content, multiple formulation procedures, and characterization of NLCs, which are pivotal aspects for establishing stable drug delivery systems.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/mns/10.2174/0118764029322000240925065749
2024-10-11
2024-11-26

  • From This Site

    /content/journals/mns/10.2174/0118764029322000240925065749
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Wang H. Liu S. Jia L. Chu F. Zhou Y. He Z. Guo M. Chen C. Xu L. Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy. Cancer Cell Int. 2018 18 1 101 10.1186/s12935‑018‑0596‑x 30008618
    [Google Scholar]
  2. Iqbal M.A. Md S. Sahni J.K. Baboota S. Dang S. Ali J. Nanostructured lipid carriers system: Recent advances in drug delivery. J. Drug Target. 2012 20 10 813 830 10.3109/1061186X.2012.716845 22931500
    [Google Scholar]
  3. Fang C.L. Al-Suwayeh S.A. Fang J.Y. Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat. Nanotechnol. 2013 7 1 41 55 10.2174/187221013804484827 22946628
    [Google Scholar]
  4. Haider M. Abdin S.M. Kamal L. Orive G. Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics 2020 12 3 288 10.3390/pharmaceutics12030288 32210127
    [Google Scholar]
  5. Subramaniam B. Siddik Z.H. Nagoor N.H. Optimization of nanostructured lipid carriers: Understanding the types, designs, and parameters in the process of formulations. J. Nanopart. Res. 2020 22 6 141 10.1007/s11051‑020‑04848‑0
    [Google Scholar]
  6. Gomaa E. Fathi H.A. Eissa N.G. Elsabahy M. Methods for preparation of nanostructured lipid carriers. Methods 2022 199 3 8 10.1016/j.ymeth.2021.05.003 33992771
    [Google Scholar]
  7. Müller RH Alexiev U Sinambela P Keck CM Nanostructured Lipid Carriers (NLC): The Second Generation of Solid Lipid Nanoparticles. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement Cham Springer 2016
    [Google Scholar]
  8. Abdel-Mageed H.M. Abd El Aziz A.E. Mohamed S.A. AbuelEzz N.Z. The tiny big world of solid lipid nanoparticles and nanostructured lipid carriers: An updated review. J. Microencapsul. 2022 39 1 72 94 10.1080/02652048.2021.2021307 34958628
    [Google Scholar]
  9. Poonia N. Kharb R. Lather V. Pandita D. Nanostructured lipid carriers: Versatile oral delivery vehicle. Future Sci. OA 2016 2 3 FSO135 10.4155/fsoa‑2016‑0030 28031979
    [Google Scholar]
  10. Narang J.K. Khan S. Baboota S. Ali J. Khan S. Narang R. Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs. Int. J. Pharm. Investig. 2015 5 4 182 191 10.4103/2230‑973X.167661 26682188
    [Google Scholar]
  11. Duong V.A. Nguyen T.T.L. Maeng H.J. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules 2020 25 20 4781 10.3390/molecules25204781 33081021
    [Google Scholar]
  12. Shirodkar R.K. Kumar L. Mutalik S. Lewis S. Solid lipid nanoparticles and nanostructured lipid carriers: Emerging lipid based drug delivery systems. Pharm. Chem. J. 2019 53 5 440 453 10.1007/s11094‑019‑02017‑9
    [Google Scholar]
  13. Doktorovová S. Kovačević A.B. Garcia M.L. Souto E.B. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2016 108 235 252 10.1016/j.ejpb.2016.08.001 27519829
    [Google Scholar]
  14. Akbari J. Saeedi M. Ahmadi F. Hashemi S.M.H. Babaei A. Yaddollahi S. Rostamkalaei S.S. Asare-Addo K. Nokhodchi A. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration. Pharm. Dev. Technol. 2022 27 5 525 544 10.1080/10837450.2022.2084554 35635506
    [Google Scholar]
  15. Viegas C. Patrício A.B. Prata J.M. Nadhman A. Chintamaneni P.K. Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: A comparative review. Pharmaceutics 2023 15 6 1593 10.3390/pharmaceutics15061593 37376042
    [Google Scholar]
  16. Patil T.S. Deshpande A.S. Nanostructured lipid carriers-based drug delivery for treating various lung diseases: A State‐of‐the‐Art Review. Int. J. Pharm. 2018 547 1-2 209 225 10.1016/j.ijpharm.2018.05.070 29859922
    [Google Scholar]
  17. Beloqui A. del Pozo-Rodríguez A. Isla A. Rodríguez-Gascón A. Solinís M.Á. Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs. J. Drug Deliv. Sci. Technol. 2017 42 144 154 10.1016/j.jddst.2017.06.013
    [Google Scholar]
  18. Vitorino C. Almeida A. Sousa J. Lamarche I. Gobin P. Marchand S. Couet W. Olivier J.C. Pais A. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: In vitro vs. in vivo studies. Eur. J. Pharm. Biopharm. 2014 86 2 133 144 10.1016/j.ejpb.2013.12.004 24333401
    [Google Scholar]
  19. Patel P. Patel M. Nanostructured lipid carriers-a versatile carrier for oral delivery of lipophilic drugs. Recent Pat. Nanotechnol. 2021 15 2 154 164 10.2174/1872210514666200909154959 32912129
    [Google Scholar]
  20. Uner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems. Pharmazie 2006 61 25 375 86
    [Google Scholar]
  21. Luan J. Zheng F. Yang X. Yu A. Zhai G. Nanostructured lipid carriers for oral delivery of baicalin: In vitro and in vivo evaluation. Colloids Surf. A Physicochem. Eng. Asp. 2015 466 154 159 10.1016/j.colsurfa.2014.11.015
    [Google Scholar]
  22. Salvi V.R. Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. J. Drug Deliv. Sci. Technol. 2019 51 255 267 10.1016/j.jddst.2019.02.017
    [Google Scholar]
  23. Mohammadi-Samani S. Ghasemiyeh P. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages. Res. Pharm. Sci. 2018 13 4 288 303 10.4103/1735‑5362.235156 30065762
    [Google Scholar]
  24. Gaba B. Fazil M. Ali A. Baboota S. Sahni J.K. Ali J. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Deliv. 2015 22 6 691 700 10.3109/10717544.2014.898110 24670099
    [Google Scholar]
  25. Wathoni N. Suhandi C. Elamin K. Lesmana R. Hasan N. Mohammed A. El-Rayyes A. Wilar G. Advancements and Challenges of Nanostructured Lipid Carriers for Wound Healing Applications. Int. J. Nanomedicine 2024 19 8091 8113 10.2147/IJN.S478964 39161361
    [Google Scholar]
  26. Khosa A. Reddi S. Saha R.N. Nanostructured lipid carriers for site-specific drug delivery. Biomed. Pharmacother. 2018 103 598 613 10.1016/j.biopha.2018.04.055 29677547
    [Google Scholar]
  27. Javed S. Mangla B. Almoshari Y. Sultan M.H. Ahsan W. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnol. Rev. 2022 11 1 1744 1777 10.1515/ntrev‑2022‑0109
    [Google Scholar]
  28. Gordillo-Galeano A. Mora-Huertas C.E. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur. J. Pharm. Biopharm. 2018 133 285 308 10.1016/j.ejpb.2018.10.017 30463794
    [Google Scholar]
  29. Obeidat W.M. Schwabe K. Müller R.H. Keck C.M. Preservation of nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 2010 76 1 56 67 10.1016/j.ejpb.2010.05.001 20452422
    [Google Scholar]
  30. Mahant S. Rao R. Souto E.B. Nanda S. Analytical tools and evaluation strategies for nanostructured lipid carrier-based topical delivery systems. Expert Opin. Drug Deliv. 2020 17 7 963 992 10.1080/17425247.2020.1772750 32441158
    [Google Scholar]
  31. Han F. Li S. Yin R. Liu H. Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloids Surf. A Physicochem. Eng. Asp. 2008 315 1-3 210 216 10.1016/j.colsurfa.2007.08.005
    [Google Scholar]
  32. Nasirizadeh S. Malaekeh-Nikouei B. Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery. J. Drug Deliv. Sci. Technol. 2020 55 101458 10.1016/j.jddst.2019.101458
    [Google Scholar]
  33. Khurana S. Utreja P. Tiwary A.K. Jain N.K. Jain S. Nanostructured Lipid Carriers and their application in drug delivery. Int. J. Biomed. Eng. Technol. 2009 2 2 152 171 10.1504/IJBET.2009.022913
    [Google Scholar]
  34. Jia L. Zhang D. Li Z. Duan C. Wang Y. Feng F. Wang F. Liu Y. Zhang Q. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies. Colloids Surf. B Biointerfaces 2010 80 2 213 218 10.1016/j.colsurfb.2010.06.008 20621458
    [Google Scholar]
  35. Pyo S.M. Müller R.H. Keck C.M. Encapsulation by nanostructured lipid carriers. Nanoencapsulation technologies for the food and nutraceutical industries. Cambridge, Massachusetts Academic Press 2017 114 137 10.1016/B978‑0‑12‑809436‑5.00004‑5
    [Google Scholar]
  36. Shah N.V. Seth A.K. Balaraman R. Aundhia C.J. Maheshwari R.A. Parmar G.R. Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study. J. Adv. Res. 2016 7 3 423 434 10.1016/j.jare.2016.03.002 27222747
    [Google Scholar]
  37. Nobari Azar F.A. Pezeshki A. Ghanbarzadeh B. Hamishehkar H. Mohammadi M. Nanostructured lipid carriers: Promising delivery systems for encapsulation of food ingredients. J. Agr. Food Res. 2020 2 100084 10.1016/j.jafr.2020.100084
    [Google Scholar]
  38. Khan S. Sharma A. Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv. Pharm. Bull. 2023 13 3 446 460 10.34172/apb.2023.056 37646052
    [Google Scholar]
  39. Jain P Rahi P Pandey V Asati S Soni V. Nanostructure lipid carriers: A modish contrivance to overcome the ultraviolet effects. Egyptian J. Basic Appl. Sci. 2017 4 2 001 10.1016/j.ejbas.2017.02.001
    [Google Scholar]
  40. Hajiaghapour Asr M. Dayani F. Saedi Segherloo F. Kamedi A. Neill A.O. MacLoughlin R. Doroudian M. Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections. Pharmaceutics 2023 15 4 1127 10.3390/pharmaceutics15041127 37111613
    [Google Scholar]
  41. Alavi S.E. Bakht U. Koohi Moftakhari Esfahani M. Adelnia H. Abdollahi S.H. Ebrahimi Shahmabadi H. Raza A. A PEGylated nanostructured lipid carrier for enhanced oral delivery of antibiotics. Pharmaceutics 2022 14 8 1668 10.3390/pharmaceutics14081668 36015294
    [Google Scholar]
  42. Nogueira N.C. de Sá L.L.F. de Carvalho A.L.M. Nanostructured lipid carriers as a novel strategy for topical antifungal therapy. AAPS PharmSciTech 2021 23 1 32 10.1208/s12249‑021‑02181‑w 34931256
    [Google Scholar]
  43. Ojha S. Mishra S. Nanostructured Lipid Carriers for Targeting Central Nervous System: Recent Advancements. Micro Nanosyst. 2023 15 2 82 91 10.2174/1876402915666230518121949
    [Google Scholar]
  44. Santos L.A. Carneiro G. Solid lipid nanoparticles and nanostructured lipid carriers for drug delivery applications. Nanomaterials. Nanomater.: Evol.Adv. Towards Therapeut. Drug Deliv. 2021 1 305 313
    [Google Scholar]
  45. Ugwu A.A. Nnamani P.O. Attama A.A. Preliminary characterization of PEGylated nanostructured lipid carriers as potential drug delivery system. J. Appl. Sci. Environ. Manag. 2024 28 1 79 84 10.4314/jasem.v28i1.9
    [Google Scholar]
  46. Alatawi H.M. Alhwiti S.S. Alsharif K.A. Albalawi S.S. Abusaleh S.M. Sror G.K. Qushawy M. Nanostructured Lipid Carriers (NLCs) as Effective Drug Delivery Systems: Methods of Preparation and their Therapeutic Applications. Recent Pat. Nanotechnol. 2024 18 2 179 189 10.2174/1872210517666230120142439 38197417
    [Google Scholar]
  47. Ferreira K.C.B. Valle A.B.C.S. Paes C.Q. Tavares G.D. Pittella F. Tavares G.D. Pittella F. Nanostructured Lipid Carriers for the Formulation of Topical Anti-Inflammatory Nanomedicines Based on Natural Substances. Pharmaceutics 2021 13 9 1454 10.3390/pharmaceutics13091454 34575531
    [Google Scholar]
  48. Andonova V. Peneva P. Characterization methods for solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC). Curr. Pharm. Des. 2018 23 43 6630 6642 10.2174/1381612823666171115105721 29141534
    [Google Scholar]
  49. Kumar V. Nair S.C. Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances. Recent Pat. Biotechnol. 2024 18 1 2 21 10.2174/1872208317666230320164219 38205772
    [Google Scholar]
  50. Singh C.P. Rai P.K. Kumar M. Tiwari V. Tiwari A. Sharma A. Sharma K. Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics. Pharm. Nanotechnol. 2024 12 2 126 142 10.2174/2211738511666230727102213 37519002
    [Google Scholar]
  51. Morales Montecinos J Sepúlveda Rivas S Oyarzún Ampuero F Lavandero González S Kogan Bocian
    [Google Scholar]
  52. Morales J.O. Novel Nanostructured Polymeric Carriers to Enable Drug Delivery for Cardiovascular Diseases. Curr. Pharm. Des. 2015 21 29 4726 84
    [Google Scholar]
  53. Gugleva V. Andonova V. Recent progress of solid lipid nanoparticles and nanostructured lipid carriers as ocular drug delivery platforms. Pharmaceuticals (Basel) 2023 16 3 474 10.3390/ph16030474 36986574
    [Google Scholar]
  54. Gad S. fawzy adel Hamadi T. Ghourab M. Nanostructured Lipid Carriers as Novel Drug Delivery System: A Review. Records Pharmaceut. Biomed. Sci. 2023 7 3 122 133 10.21608/rpbs.2023.214962.1232
    [Google Scholar]
  55. Tang C.H. Chen H.L. Dong J.R. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as food-grade nanovehicles for hydrophobic nutraceuticals or bioactives. Appl. Sci. (Basel) 2023 13 3 1726 10.3390/app13031726
    [Google Scholar]
  56. Bonaccorso A. Ortis A. Musumeci T. Carbone C. Hussain M. Di Salvatore V. Battiato S. Pappalardo F. Pignatello R. Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature. Int. J. Nanomedicine 2024 19 5619 5636 10.2147/IJN.S452316 38882536
    [Google Scholar]
  57. Garg J. Pathania K. Sah S.P. Pawar S.V. Nanostructured lipid carriers: A promising drug carrier for targeting brain tumours. Future J. Pharmaceut. Sci. 2022 8 1 25 10.1186/s43094‑022‑00414‑8
    [Google Scholar]
  58. Paolino D. Nanostructured lipid carriers (NLC) for the topical delivery of lutein. Drug Deliv. Lett. 2011 1 1 32 39 10.2174/2210303111101010032
    [Google Scholar]
  59. Shrivastava P. Gautam L. Jain A. Vishwakarma N. Vyas S. Vyas S.P. Lipid drug conjugates for improved therapeutic benefits. Curr. Pharm. Des. 2020 26 27 3187 3202 10.2174/1381612826666200311124003 32160838
    [Google Scholar]
  60. Chen Y. Yang X. Zhao L. Almásy L. Garamus V.M. Willumeit R. Zou A. Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug. Colloids Surf. A Physicochem. Eng. Asp. 2014 455 36 43 10.1016/j.colsurfa.2014.04.032
    [Google Scholar]
  61. Costa C.P. Moreira J.N. Sousa Lobo J.M. Silva A.C. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharm. Sin. B 2021 11 4 925 940 10.1016/j.apsb.2021.02.012 33996407
    [Google Scholar]
  62. Gunawan M. Boonkanokwong V. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review. Colloids Surf. B Biointerfaces 2024 233 113608 10.1016/j.colsurfb.2023.113608 37925866
    [Google Scholar]
  63. Rajoriya V. Gupta R. Vengurlekar S. Surendra Singh U. Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting. Int. J. Pharm. 2024 655 123986 10.1016/j.ijpharm.2024.123986 38493842
    [Google Scholar]
  64. Chen X. Wang Z.X. Liu W. Wu Y.C. Li H.J. Understanding the nanostructures of prolamin-based oral carrier to deliver functional compounds: A review. Trends Food Sci. Technol. 2024 150 104571 10.1016/j.tifs.2024.104571
    [Google Scholar]
  65. Huang R. He L. Jin L. Li Z. He N. Miao W. Recent advancements in DNA nanotechnology-enabled extracellular vesicles detection and diagnosis: A mini review. Chin. Chem. Lett. 2023 34 6 107926 10.1016/j.cclet.2022.107926
    [Google Scholar]
  66. Ma Y. Li S. Lin X. Chen Y. A perspective of lipid nanoparticles for RNA delivery. Exploration 2024 2024 20230147 10.1002/EXP.20230147
    [Google Scholar]
  67. Singh B. Kumar M. Upadhyay P.K. Singh A.K. Nanostructured Lipid Carrier for Dermatological Application: A Comprehensive Review and Future Perspective. Curr. Nanomed. 2024 14 3 188 199 10.2174/0124681873274871230927105142
    [Google Scholar]
  68. Quadir SS Joshi G Saharan V Mangesh H Choudhary D Yadav K Jain CP Chauhan LS A Review on Nanostructured Lipid Carriers as Promising Drug Delivery Vehicle to Target Various Cancers via Oral Route: A Step towards “Chemotherapy at Home”. Curr. Nanomed. 2024 14 2 92452
    [Google Scholar]
  69. Alwahsh W. Sahudin S. Alkhatib H. Bostanudin M.F. Alwahsh M. Chitosan-Based Nanocarriers for Pulmonary and Intranasal Drug Delivery Systems: A Comprehensive Overview of their Applications. Curr. Drug Targets 2024 25 7 492 511 10.2174/0113894501301747240417103321 38676513
    [Google Scholar]
/content/journals/mns/10.2174/0118764029322000240925065749
Loading
Guiding Therapeutics: Lipid Labyrinths and Nanostructures for Enhanced Drug Delivery
Bentham Science Publishers ; https://doi.org/10.2174/0118764029322000240925065749
/content/journals/mns/10.2174/0118764029322000240925065749
/content/journals/mns/10.2174/0118764029322000240925065749
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Nanostructured lipid carriers ; solvent evaporation ; biocompatible ; microemulsion ; melt emulsification ; high pressure homogenization

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test